{
  "trial_id": "NCT01206062",
  "trial_group": "chronic kidney disease",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, gender, race/ethnicity, baseline systolic blood pressure, baseline diastolic blood pressure, number of antihypertensive medications, presence of clinical or subclinical cardiovascular disease, chronic kidney disease status, Framingham Risk Score, smoking status, body mass index (BMI), history of diabetes mellitus, history of stroke, history of polycystic kidney disease, history of glomerulonephritis, eGFR, history of cardiovascular events or procedures, history of heart failure, left ventricular ejection fraction, history of malignancy, adherence to interventions, informed consent status, participation in other clinical trials, household status with other participants, history of organ transplant, unintentional weight loss, pregnancy status.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "gender"
        ],
        [
          "Race/Ethnicity",
          "race/ethnicity"
        ],
        [
          "Estimated GFR",
          "eGFR"
        ],
        [
          "Criterion for increased cardiovascular risk",
          "presence of clinical or subclinical cardiovascular disease"
        ],
        [
          "Baseline BP mm Hg",
          "baseline systolic blood pressure"
        ],
        [
          "Framingham 10-yr cardiovascular disease risk score",
          "Framingham Risk Score"
        ],
        [
          "Smoking status - no. (%)",
          "smoking status"
        ],
        [
          "Body-mass index",
          "body mass index (BMI)"
        ],
        [
          "Antihypertensive agents - no./patient",
          "number of antihypertensive medications"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Black race",
        "Distribution of systolic blood pressure",
        "Serum creatinine",
        "Ratio of urinary albumin (mg) to creatinine (g)",
        "Fasting total cholesterol - mg/dl",
        "Fasting HDL cholesterol - mg/dl",
        "Fasting total triglycerides - mg/dl",
        "Fasting plasma glucose - mg/dl",
        "Statin use",
        "Aspirin use",
        "Not using antihypertensive agents - no. (%)"
      ],
      "remaining_candidate_features": [
        "baseline diastolic blood pressure",
        "chronic kidney disease status",
        "history of diabetes mellitus",
        "history of stroke",
        "history of polycystic kidney disease",
        "history of glomerulonephritis",
        "history of cardiovascular events or procedures",
        "history of heart failure",
        "left ventricular ejection fraction",
        "history of malignancy",
        "adherence to interventions",
        "informed consent status",
        "participation in other clinical trials",
        "household status with other participants",
        "history of organ transplant",
        "unintentional weight loss",
        "pregnancy status"
      ]
    },
    "processed-gen-response": "Age, gender, race/ethnicity, baseline systolic blood pressure, baseline diastolic blood pressure, number of antihypertensive medications, presence of clinical or subclinical cardiovascular disease, chronic kidney disease status, Framingham Risk Score, smoking status, body mass index (BMI), history of diabetes mellitus, history of stroke, history of polycystic kidney disease, history of glomerulonephritis, eGFR, history of cardiovascular events or procedures, history of heart failure, left ventricular ejection fraction, history of malignancy, adherence to interventions, informed consent status, participation in other clinical trials, household status with other participants, history of organ transplant, unintentional weight loss, pregnancy status."
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Systolic Blood Pressure, Diastolic Blood Pressure, Number of Antihypertensive Medications, eGFR, Presence of Clinical or Subclinical Cardiovascular Disease, Chronic Kidney Disease (CKD) Status, Framingham Risk Score,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race/Ethnicity",
          "Race/Ethnicity"
        ],
        [
          "Estimated GFR",
          "eGFR"
        ],
        [
          "Criterion for increased cardiovascular risk",
          "Presence of Clinical or Subclinical Cardiovascular Disease"
        ],
        [
          "Baseline BP mm Hg",
          "Systolic Blood Pressure"
        ],
        [
          "Framingham 10-yr cardiovascular disease risk score",
          "Framingham Risk Score"
        ],
        [
          "Antihypertensive agents - no./patient",
          "Number of Antihypertensive Medications"
        ]
      ],
      "remaining_reference_features": [
        "Black race",
        "Distribution of systolic blood pressure",
        "Serum creatinine",
        "Ratio of urinary albumin (mg) to creatinine (g)",
        "Fasting total cholesterol - mg/dl",
        "Fasting HDL cholesterol - mg/dl",
        "Fasting total triglycerides - mg/dl",
        "Fasting plasma glucose - mg/dl",
        "Statin use",
        "Aspirin use",
        "Smoking status - no. (%)",
        "Body-mass index",
        "Not using antihypertensive agents - no. (%)"
      ],
      "remaining_candidate_features": [
        "Region of Enrollment",
        "Diastolic Blood Pressure",
        "Chronic Kidney Disease (CKD) Status"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, Systolic Blood Pressure, Diastolic Blood Pressure, Number of Antihypertensive Medications, eGFR, Presence of Clinical or Subclinical Cardiovascular Disease, Chronic Kidney Disease (CKD) Status, Framingham Risk Score"
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, History of Cardiovascular Disease, Systolic Blood Pressure, Diastolic Blood Pressure, eGFR, Framingham Risk Score, Body Mass Index, History of Chronic Kidney Disease, History of Diabetes Mellitus.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race/Ethnicity",
          "Race/Ethnicity"
        ],
        [
          "Estimated GFR",
          "eGFR"
        ],
        [
          "Criterion for increased cardiovascular risk",
          "History of Cardiovascular Disease"
        ],
        [
          "Baseline BP mm Hg",
          "Systolic Blood Pressure"
        ],
        [
          "Framingham 10-yr cardiovascular disease risk score",
          "Framingham Risk Score"
        ],
        [
          "Body-mass index",
          "Body Mass Index"
        ]
      ],
      "remaining_reference_features": [
        "Black race",
        "Distribution of systolic blood pressure",
        "Serum creatinine",
        "Ratio of urinary albumin (mg) to creatinine (g)",
        "Fasting total cholesterol - mg/dl",
        "Fasting HDL cholesterol - mg/dl",
        "Fasting total triglycerides - mg/dl",
        "Fasting plasma glucose - mg/dl",
        "Statin use",
        "Aspirin use",
        "Smoking status - no. (%)",
        "Antihypertensive agents - no./patient",
        "Not using antihypertensive agents - no. (%)"
      ],
      "remaining_candidate_features": [
        "Region of Enrollment",
        "Diastolic Blood Pressure",
        "History of Chronic Kidney Disease",
        "History of Diabetes Mellitus."
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, History of Cardiovascular Disease, Systolic Blood Pressure, Diastolic Blood Pressure, eGFR, Framingham Risk Score, Body Mass Index, History of Chronic Kidney Disease, History of Diabetes Mellitus."
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ethnicity, body mass index (BMI), systolic blood pressure (SBP), diastolic blood pressure (DBP), heart rate, Framingham Risk Score, estimated glomerular filtration rate (eGFR), presence of clinical or subclinical cardiovascular disease, history of stroke, history of heart failure, left ventricular ejection fraction, presence of chronic kidney disease, proteinuria, diabetes mellitus, smoking status, use of antihypertensive medications, use of statins, use of aspirin.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Race/Ethnicity",
          "race"
        ],
        [
          "Estimated GFR",
          "estimated glomerular filtration rate (eGFR)"
        ],
        [
          "Criterion for increased cardiovascular risk",
          "presence of clinical or subclinical cardiovascular disease"
        ],
        [
          "Baseline BP mm Hg",
          "systolic blood pressure (SBP)"
        ],
        [
          "Framingham 10-yr cardiovascular disease risk score",
          "Framingham Risk Score"
        ],
        [
          "Body-mass index",
          "body mass index (BMI)"
        ],
        [
          "Antihypertensive agents - no./patient",
          "use of antihypertensive medications"
        ],
        [
          "Statin use",
          "use of statins"
        ],
        [
          "Aspirin use",
          "use of aspirin"
        ],
        [
          "Smoking status - no. (%)",
          "smoking status"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Black race",
        "Distribution of systolic blood pressure",
        "Serum creatinine",
        "Ratio of urinary albumin (mg) to creatinine (g)",
        "Fasting total cholesterol - mg/dl",
        "Fasting HDL cholesterol - mg/dl",
        "Fasting total triglycerides - mg/dl",
        "Fasting plasma glucose - mg/dl",
        "Not using antihypertensive agents - no. (%)"
      ],
      "remaining_candidate_features": [
        "ethnicity",
        "diastolic blood pressure (DBP)",
        "heart rate",
        "history of stroke",
        "history of heart failure",
        "left ventricular ejection fraction",
        "presence of chronic kidney disease",
        "proteinuria",
        "diabetes mellitus"
      ]
    },
    "processed-gen-response": "Age, sex, race, ethnicity, body mass index (BMI), systolic blood pressure (SBP), diastolic blood pressure (DBP), heart rate, Framingham Risk Score, estimated glomerular filtration rate (eGFR), presence of clinical or subclinical cardiovascular disease, history of stroke, history of heart failure, left ventricular ejection fraction, presence of chronic kidney disease, proteinuria, diabetes mellitus, smoking status, use of antihypertensive medications, use of statins, use of aspirin."
  }
}